OmniAb Executives Trade Small, Steady: Chief Legal Officer Buys More While CFO and CEO Flip Shares, Hinting at Liquidity Management Over Market Moves
Insider buying by OmniAb’s Chief Legal Officer shows confidence in its therapeutic antibody platform, while frequent small trades suggest liquidity‑focused management rather than price‑moving bets.
4 minutes to read
